Daniel Paul Regan Insider Trading $ICPT INTERCEPT PHARMACEUTICALS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Daniel Paul Regan.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Daniel Paul Regan. Daniel Paul Regan is Chief Commercial Officer in INTERCEPT PHARMACEUTICALS INC ($ICPT).

Daniel Paul Regan in INTERCEPT PHARMACEUTICALS, INC.

Trading Symbol: ICPT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Daniel Paul Regan: Chief Commercial Officer
Holdings: 1,264 shares
Current Value: $143,552
Latest Transaction: Feb 03 2015
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Daniel Paul Regan in INTERCEPT PHARMACEUTICALS, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 03 2015ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...Option ExerciseM37.699,847371,13392,028
Feb 03 2015ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS208.0820041,6161,2641.5 K to 1.3 K (-13.66 %)
Feb 03 2015ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS205.87800164,6981,4642.3 K to 1.5 K (-35.34 %)
Feb 03 2015ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS202.49793160,5772,2643.1 K to 2.3 K (-25.94 %)
Feb 03 2015ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS201.501,207243,2133,0574.3 K to 3.1 K (-28.31 %)
Feb 03 2015ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS200.076,8471,369,8594,26411.1 K to 4.3 K (-61.62 %)
Feb 03 2015ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...BuyM37.699,847371,13311,1111.3 K to 11.1 K (+779.03 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...Option ExerciseM37.698,124306,194101,875
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS346.6822477,6561,4101.6 K to 1.4 K (-13.71 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS344.73500172,3661,6342.1 K to 1.6 K (-23.43 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS343.80800275,0392,1342.9 K to 2.1 K (-27.27 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS342.05300102,6142,9343.2 K to 2.9 K (-9.28 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS341.21300102,3623,2343.5 K to 3.2 K (-8.49 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS337.1710033,7173,5343.6 K to 3.5 K (-2.75 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS336.4720067,2933,6343.8 K to 3.6 K (-5.22 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS335.0210033,5023,8343.9 K to 3.8 K (-2.54 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS331.9220066,3843,9344.1 K to 3.9 K (-4.84 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS330.9120668,1674,1344.3 K to 4.1 K (-4.75 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS329.59594195,7774,3404.9 K to 4.3 K (-12.04 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS327.8930098,3664,9345.2 K to 4.9 K (-5.73 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS326.0310032,6035,2345.3 K to 5.2 K (-1.87 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS322.9210032,2925,3345.4 K to 5.3 K (-1.84 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS321.4420064,2885,4345.6 K to 5.4 K (-3.55 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS319.47400127,7875,6346 K to 5.6 K (-6.63 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS317.71400127,0826,0346.4 K to 6 K (-6.22 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS316.6220063,3246,4346.6 K to 6.4 K (-3.01 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS314.93600188,9556,6347.2 K to 6.6 K (-8.29 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS313.84800251,0727,2348 K to 7.2 K (-9.96 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS312.7820062,5558,0348.2 K to 8 K (-2.43 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS311.89500155,9438,2348.7 K to 8.2 K (-5.72 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS310.11500155,0528,7349.2 K to 8.7 K (-5.41 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS306.9110030,6919,2349.3 K to 9.2 K (-1.07 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS305.3920061,0779,3349.5 K to 9.3 K (-2.10 %)
Aug 15 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...BuyM37.698,124306,1949,5341.4 K to 9.5 K (+576.17 %)
Jul 08 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...Option ExerciseM37.69138109,999
Jul 08 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...SellS250.0012501,4101.4 K to 1.4 K (-0.07 %)
Jul 08 2014ICPTINTERCEPT PHARMACE ...Regan Daniel PaulChief Commercial Of ...BuyM37.691381,4111.4 K to 1.4 K (+0.07 %)

Page:   1